Immunome Inc. (IMNM) at a glance

Immunome Inc. (IMNM) is a mid-cap Healthcare company. It trades at $27.62, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 36/100 overall. Its strongest dimension is Momentum (78/100) and its weakest is Growth (10/100). It carries above-market volatility, so expect larger swings.

Price

$27.62

Market cap

$2.08B

P/E ratio

n/a

Dividend yield

None

Beta

2.07

52-week range

$8.67 to $30.06